+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Treatment of aggressive non-Hodgkin's lymphoma in elderly patients with thiotepa, Novantrone (mitoxantrone), vincristine, prednisone (TNOP)



Treatment of aggressive non-Hodgkin's lymphoma in elderly patients with thiotepa, Novantrone (mitoxantrone), vincristine, prednisone (TNOP)



American Journal of Clinical Oncology 24(4): 360-362



The aging of the population and the increased incidence of non-Hodgkin's lymphoma will result in a large number of elderly patients with this disorder. Newer therapies will be required for this group of patients. This article reports a new therapy for elderly patients with diffuse aggressive non-Hodgkin's lymphoma.

(PDF emailed within 0-6 h: $19.90)

Accession: 011591166

Download citation: RISBibTeXText

PMID: 11474261

DOI: 10.1097/00000421-200108000-00008


Related references

Treatment of aggressive non-Hodgkins lymphoma in elderly patients with thiotepa, Novantrone , vincristine, prednisone. American Journal of Clinical Oncology 24(4): 360-362, August, 2001

Treatment of elderly patients with intermediate and high grade non-Hodgkins lymphoma A trial of thiotepa, novantrone , oncovin and prednisone. Blood 84(10 SUPPL 1): 164A, 1994

Mitoxantrone, prednimustine, and vincristine for elderly patients with aggressive non-Hodgkin's lymphoma. American Journal of Hematology 59(2): 156-160, 1998

Weekly administration of vincristine, cyclophosphamide, mitoxantrone and bleomycin (VEMB) in the treatment of elderly aggressive non Hodgkin's lymphoma. Haematologica 83(3): 217-221, 1998

A phase II trial of prednisone, oral etoposide, and novantrone (PEN) as initial treatment of non-Hodgkin's lymphoma in elderly patients. Leukemia & Lymphoma 18(1-2): 145-152, 1995

Weekly administration of vincristine, cyclophosphamide, mitoxantrone and bleomycin (VEMB) in the treatment of elderly aggressive non Hodgkin's lymphoma. Gruppo Italiano per lo Studio dei Linfomi. Haematologica 83(3): 217-221, 1998

Cyclophosphamide, mitoxantrone, vincristine and prednisone in the treatment of non-Hodgkin's lymphoma. Oncology 45(5): 378-379, 1988

VNCOP-B (etoposide, mitoxantrone, cyclophosphamide, vincristine, predonisolone, bleomycin) therapy in elderly patients with aggressive non-Hodgkin lymphoma--a study of efficacy and safety, final report. Gan to Kagaku Ryoho. Cancer & ChemoTherapy 32(1): 39-44, 2005

Prednimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma. Leukemia (Basingstoke) 10(5): 836-843, 1996

Prednimustine, mitoxantrone versus cyclophosphamide, vincristine, prednisone for the treatment of advanced low grade non Hodgkin lymphoma. Blood 84(10 SUPPL 1): 168A, 1994

Equitoxicity of bolus and infusional etoposide: results of a multicenter randomised trial of the German High-Grade Non-Hodgkins Lymphoma Study Group (DSHNHL) in elderly patients with refractory or relapsing aggressive non-Hodgkin lymphoma using the CEMP regimen (cisplatinum, etoposide, mitoxantrone and prednisone). Annals of Hematology 87(9): 717-726, 2008

Treatment of aggressive non-Hodgkins lymphoma in the elderly with mitoxantrone, prednimustine and vincristine. Blood 82(10 SUPPL 1): 564A, 1993

Prednimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma. German Low-Grade Lymphoma Study Group. Leukemia 10(5): 836-843, 1996

Mesna/ifosfamide, mitoxantrone, etoposide, bleomycin, vincristine, prednisone (MINE-BOP) combination chemotherapy in the treatment of refractory and relapsed non-Hodgkin's lymphoma. Acta Oncologica (Stockholm) 34(7): 937-940, 1995